Interim Data from the MyPEAK-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy Presentation (6d54b9)

Tenaya Therapeutics Inc. published this content on June 03, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 03, 2026 at 11:57 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]